Current Opinion in Lipidology volume 27, issue 6, P592-596 2016 DOI: 10.1097/mol.0000000000000349 View full text
|
|
Share
Kang H. Zheng, Erik S.G. Stroes

Abstract: Clinical studies are currently ongoing to evaluate the potential of several HDL mimetic drugs. Novel nanomedicinal approaches and emerging pathophysiological insights may further expand the relevance of HDL infusion.